Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
Markey Calls for Investigation into Purdue
United States Senator Edward J. Markey has called for a federal investigation of OxyContin's manufacturers in response to a Los…
Utah “Suggestion Sheet” of Ideas to Combat Opioid Epidemic
It's no secret that state legislatures are under intense pressure to take action to battle the opioid addiction problems…
Shatterproof Report on Critical Elements of Effective State Opioid…
The opioid epidemic has been a prominent talking point in many circles lately, including physician groups, Congress,…
Senator Durbin Asks Medical Associations to Endorse Mandatory Opioid CME –…
Following last month's letter to the Pharmaceutical Research and Manufacturers of America (PhRMA), asking the group to "take…
CNN Special Report on Prescription Addiction
We have been talking about the opioid addiction in America for several months now, from Congressional hearings, to new…
FDA ER-LA REMS Day 2 of the Drug Safety and Risk Management Advisory…
Day Two of the Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and…
FDA ER-LA REMS Day One of Meeting of the Drug Safety and Risk Management…
The Food and Drug Administration (FDA) is hosting a two-day long Joint Meeting of the Drug Safety and Risk Management…
CME and the Opioid Crisis
Dramatic increases in death due to prescription opioid abuse has gained national attention. In the last month alone, the…
FDA Opinion on Proactive Response to Prescription Opioid Abuse
Opioid abuse has been in the news for the past few months, and it seems as though it will continue to be in the news for…
FDA Announces Labeling Changes for Immediate Release Opioid Medications
The United States Food and Drug Administration has announced new required class-wide safety labeling changes for…